China Steroid Hormone Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the China Steroid Hormone Market was valued at USD 1.85 billion in 2025 and is projected to reach USD 2.82 billion by 2032, growing at a CAGR of approximately 6.2% during 2026–2032.
China Steroid Hormone Market Highlights
| Report Metric | Details |
| Report Name | China Steroid Hormone Market |
| Market Size 2025 | USD 1.85 billion |
| Market Size 2032 | USD 2.82 billion |
| Absolute Growth 2025–2032 | USD 0.97 billion |
| CAGR 2026–2032 | 6.2% |
| Peak Annual Growth | 8.5% in 2029 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Hormone Type, 2025 | Corticosteroids (49% share) |
| Leading Source, 2025 | Synthetic (36% share) |
| Leading Application Area, 2025 | Anti-inflammatory Drugs (45% share) |
| Leading End User, 2025 | Pharmaceutical Companies (39% share) |
| Fastest-Growing Hormone Type | Anabolic Steroids (8.3% CAGR) |
| Fastest-Growing Source | Biosynthetic (8.4% CAGR) |
| Fastest-Growing Application Area | Muscle Growth Therapy (7.7% CAGR) |
| Fastest-Growing End User | Drug Developers (8.6% CAGR) |
| Growing Sector | Pharmaceuticals |
| Key End Users | Pharmaceutical Companies, Research Institutions, Healthcare Manufacturers, Drug Developers |
China Steroid Hormone Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Annual growth estimates for each year appear below with the principal reason behind them, explaining the shifts that set the pace of the market.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 7.4 | The market experienced strong demand from pharmaceutical companies for hormonal treatments. |
| 2023 | 5.6 | Growth slowed due to regulatory adjustments affecting the approval process for new therapies. |
| 2024 | 7.3 | Demand increased as research institutions advanced studies on biosynthetic steroid hormones. |
| 2025 | 4.9 | Aging population trends contributed to a slowdown in growth as healthcare needs intensified. |
| 2026 | 5.6 | The market is expected to improve as the National Health Commission supports new therapies. |
| 2027 | 7.1 | Increased awareness of health and fitness boosted demand for anabolic steroids in muscle growth therapy. |
| 2028 | 4.8 | Growth slowed as competition among manufacturers intensified in the steroid hormone sector. |
| 2029 | 8.5 | A surge in demand for anti-inflammatory drugs drove growth to its peak this year. |
| 2030 | 7.9 | Market growth is projected to slow as regulatory changes impact production timelines. |
| 2031 | 3.6 | The market is expected to grow at a slower rate due to increased scrutiny on anabolic steroid use. |
| 2032 | 6.0 | Demand for hormonal treatments is anticipated to rise as the population ages further. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
China Steroid Hormone Market Synopsis
The China Steroid Hormone Market includes various organic compounds that regulate physiological processes, primarily produced synthetically. These hormones play a crucial role in treating inflammatory conditions, hormonal imbalances, and certain cancers. The market is expanding due to increasing demand from pharmaceutical companies and research institutions, with corticosteroids representing around 40% of the market in 2022. An aging population and government initiatives like 'Healthy China 2030' are further propelling this growth, improving healthcare access and innovation in hormonal treatments.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Rising demand for anti-inflammatory drugs due to increasing prevalence of autoimmune diseases. | Driver | High | Corticosteroids |
| Growing awareness of health and fitness leading to increased use of anabolic steroids for muscle growth. | Driver | High | Anabolic Steroids |
| Investment in biosynthetic hormone production as a sustainable alternative is gaining traction. | Opportunity | Medium | Biosynthetic |
| Expansion of the birth control market in urban areas presents new opportunities for hormonal treatments. | Opportunity | High | Progestogens |
| Regulatory scrutiny on anabolic steroid use may limit market access for certain products. | Restraint | High | Anabolic Steroids |
| Quality assurance requirements under ISO 9001 standards can increase production costs. | Restraint | Medium | Synthetic |
| Challenges in securing funding for innovative research may hinder development timelines. | Challenge | High | Biosynthetic |
| Competition among healthcare manufacturers can lead to pricing pressures affecting profitability. | Challenge | Medium | Pharmaceutical Companies |
Evaluation of Drivers in China Steroid Hormone Market (2026–2032)
The factors lifting demand, and the evidence behind each, are summarised below.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Increasing prevalence of autoimmune diseases drives demand for corticosteroids. | Corticosteroids | In 2022, corticosteroids accounted for approximately 40% of the market, resulting in higher purchases by healthcare providers. |
| Rising fitness trends boost anabolic steroid prescriptions for muscle growth therapy. | Anabolic Steroids | Increased health awareness is leading to more prescriptions in hospitals for muscle-wasting diseases. |
| Government initiatives promote research in steroid hormone therapies. | Biosynthetic | The 'Healthy China 2030' initiative aims to improve healthcare, encouraging investment in hormone production. |
| The expanding birth control market increases demand for progestogens and estrogens. | Progestogens | The market for birth control methods is expanding, with hormonal options gaining popularity among urban populations. |
| Research institutions are advancing studies on plant-based steroid hormones. | Plant-Based | Research institutions in Beijing are focusing on developing sustainable alternatives, increasing interest in plant-based hormones. |
In 2022, corticosteroids accounted for approximately 40% of the market, driven by the prevalence of autoimmune diseases. The aging population, projected to exceed 1.4 billion in 2023, is further fuelling demand for hormonal treatments. Awareness of health and fitness is driving prescriptions for anabolic steroids in muscle growth therapy, boosting overall market activity.
Evaluation of Restraints in China Steroid Hormone Market
The table below lists the restraints and the evidence behind each.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Regulatory scrutiny on anabolic steroid use may limit market access for certain products. | Anabolic Steroids | New guidelines introduced in 2023 by the Ministry of Health affect how anabolic steroids are prescribed. |
| Quality assurance requirements under ISO 9001 standards can increase production costs. | Synthetic | Producers must comply with stringent quality standards, raising operational costs and affecting pricing. |
| Challenges in securing funding for research may hinder development timelines. | Biosynthetic | Research institutions face difficulties in obtaining grants, slowing the progress of new hormone therapies. |
| Increased competition among healthcare manufacturers can lead to pricing pressures. | Pharmaceutical Companies | With over 3,000 registered healthcare manufacturers, pricing strategies are becoming more competitive. |
| Market saturation in certain segments may limit growth potential. | Progestogens | The expanding birth control market faces saturation, making it harder for new products to gain traction. |
China Steroid Hormone Market Challenges
The China Steroid Hormone Market still has to solve a few problems, and the first is technology limitations. Many producers rely on outdated manufacturing processes, which can lead to inefficiencies and increase production costs for healthcare manufacturers. A skills shortage exists, as there is a lack of trained personnel in advanced steroid hormone production, delaying product development timelines for suppliers. Buyers face high regulatory hurdles, with the National Medical Products Administration imposing approval processes that can take up to 18 months, affecting access to new treatments. Competition is fierce, with over 3,000 registered healthcare manufacturers, making it difficult for smaller producers to gain market share and forcing them to lower prices, which can erode profitability.
Trends in the China Steroid Hormone Market
Below mentioned are some of the trends shaping the China Steroid Hormone Market growth.
- Shift Towards Biosynthetic Hormones: In 2023, research institutions in Beijing are at the forefront of biosynthetic steroid hormone studies, with government funding of 500 million yuan allocated for projects. This move towards sustainable production methods is set to reshape the market.
- Growing Demand for Muscle Growth Therapy: The market for muscle growth therapy has gained traction since 2022, with anabolic steroids being prescribed more frequently in hospitals. Increased health awareness is driving this trend, leading to a projected growth rate of 7.7% by 2032.
- Expansion of Birth Control Options: The birth control market in China is expanding, with hormonal options gaining popularity among urban populations. This trend is supported by the 'Healthy China Initiative', which aims to improve healthcare access and options for women.
- Rising Focus on Quality Standards: The implementation of ISO 9001 standards in 2022 has intensified the focus on quality in steroid hormone production. This change ensures better product safety and efficacy, benefiting both producers and consumers.
Investment Opportunities in the China Steroid Hormone Market
Some of the investment opportunities in the China Steroid Hormone Market are mentioned below.
- Investment in Biosynthetic Hormones: The demand for biosynthetic steroid hormones is on the rise, driven by sustainability concerns. Research institutions are concentrating on this area, with funding available for projects aimed at developing sustainable production methods.
- Supply of Hormonal Treatments for Aging Population: With China's aging population projected to grow, the need for hormonal treatments is increasing. Pharmaceutical companies should invest in developing new therapies to address this demographic shift.
- Expansion of Anti-inflammatory Drug Production: The market for anti-inflammatory drugs is growing, with corticosteroids leading the way. Manufacturers should focus on increasing production capacity to meet the rising demand.
- Development of New Birth Control Methods: As the birth control market expands, there is a notable opportunity for new hormonal contraceptives. Companies should collaborate with healthcare providers to ensure effective distribution.
Government Initiatives in the China Steroid Hormone Market
The National Drug Policy, launched in 2021, improves access to essential medicines, including steroid hormones. This policy aims to streamline the approval process and ensure that patients can obtain necessary treatments without delays. Additionally, the 'Healthy China Initiative' approved in 2020 focuses on improving healthcare services, positively impacting the availability of hormonal treatments across the country.
In 2022, the Ministry of Health introduced a subsidy program with a budget of 500 million yuan for research institutions developing new hormonal therapies. This funding supports projects that aim to improve the safety and efficacy of steroid hormones. The National Medical Products Administration oversees the approval process for new steroid hormone therapies, ensuring compliance with safety regulations and facilitating quicker access to market.
Future Insight of the China Steroid Hormone Market
Several forward-looking factors should support the China Steroid Hormone Market over the coming years. The 'Healthy China 2030' initiative will drive investment in healthcare, including hormonal treatments, enhancing access for buyers. Research from institutions in Beijing on biosynthetic steroid hormones will lead to more sustainable production methods, benefiting suppliers. By 2025, the market for hormonal treatments is projected to reach significant figures, driven by the aging population and increasing demand for effective therapies. New guidelines from the Ministry of Health will also promote the safe use of anabolic steroids, fostering confidence among healthcare providers.
Market Segmentation Analysis
The analysis below covers each segmentation, its leading category in 2025 and its fastest-growing category through 2032.
By Hormone Type – Corticosteroids Dominated, Anabolic Steroids Expected to Grow Fastest
According to Summon Dutta, Assistant Manager at 6Wresearch, Corticosteroids held a 49% share of the China Steroid Hormone Market by hormone type in 2025. Corticosteroids dominate the market due to their extensive use in anti-inflammatory drugs and treatments for autoimmune diseases. This segment's strong presence is reflected in its widespread application across hospitals and clinics throughout China. Anabolic Steroids are set to record the highest CAGR in this split, 8.3% over 2026–2032. The anabolic steroids segment is experiencing rapid growth, driven by increasing awareness of muscle growth therapy and its medical applications. This rise is supported by a growing fitness culture and the demand for effective treatments for muscle-wasting conditions. Suppliers should focus on expanding their product lines in anabolic steroids to meet the rising demand in the fitness and medical sectors.
By Source – Synthetic Dominated, Biosynthetic Expected to Grow Fastest
Synthetic accounted for a 36% market share by source in 2025. Synthetic steroid hormones hold the largest market share due to their reliable production methods, which ensure consistent quality and efficacy. This is particularly evident in regions like Jiangsu and Zhejiang provinces, where most of the production occurs. Over 2026–2032, Biosynthetic is expected to post the fastest growth, at a CAGR of 8.4%. Biosynthetic steroid hormones are experiencing rapid growth as a sustainable alternative, with increasing investments in environmentally friendly production methods. Government funding for research into sustainable biosynthetic hormone production is propelling this trend forward. Suppliers should consider investing in biosynthetic hormone production to meet the rising demand for sustainable pharmaceutical options.
By Application Area – Anti-inflammatory Drugs Dominated, Muscle Growth Therapy Expected to Grow Fastest
Anti-inflammatory Drugs took a 45% share of application area in 2025, more than any other category. Anti-inflammatory drugs represent the largest application area, primarily due to the extensive use of corticosteroids in treating various inflammatory conditions. This widespread application underscores the critical role of corticosteroids in the healthcare system across China. Muscle Growth Therapy is projected to grow fastest, at a CAGR of 7.7% during 2026–2032. Muscle growth therapy is rapidly expanding as anabolic steroids are increasingly prescribed for specific medical conditions, reflecting a growing acceptance of these treatments. The rise in fitness awareness further fuels this segment's growth. Pharmaceutical companies should invest in developing targeted therapies for muscle growth to capitalise on this expanding market.
By End User – Pharmaceutical Companies Dominated, Drug Developers Expected to Grow Fastest
In 2025, Pharmaceutical Companies led the end user split with a 39% share. Pharmaceutical companies lead the market share as they are the primary manufacturers and distributors of steroid hormones, providing a steady supply to healthcare providers. Their established networks and infrastructure solidify their dominant position in the industry. The quickest growth will come from Drug Developers, forecast to expand at a CAGR of 8.6% between 2026 and 2032. Drug developers are growing at the fastest rate by focusing on innovative therapies that utilise steroid hormones, which are essential for addressing evolving healthcare needs. Their emphasis on research and development is crucial for adapting to future market demands. Suppliers should collaborate with drug developers to support the advancement of innovative steroid hormone therapies that respond to emerging healthcare challenges.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- China Steroid Hormone Market Outlook
- Market Size of China Steroid Hormone Market, 2025
- Forecast of China Steroid Hormone Market, 2032
- Historical Data and Forecast of China Steroid Hormone Revenues & Volume for the Period 2022 - 2032F
- China Steroid Hormone Market Trend Evolution
- China Steroid Hormone Market Drivers and Challenges
- China Steroid Hormone Price Trends
- China Steroid Hormone Porter's Five Forces
- China Steroid Hormone Industry Life Cycle
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Hormone Type for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Corticosteroids for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Anabolic Steroids for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Estrogens & Androgens for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Progestogens for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Source for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Synthetic for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Plant-Based for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Animal-Based for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Biosynthetic for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Application Area for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Anti-inflammatory Drugs for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Muscle Growth Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Hormonal Treatments for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Birth Control for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Pharmaceutical Companies for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Research Institutions for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Healthcare Manufacturers for the Period 2022 - 2032F
- Historical Data and Forecast of China Steroid Hormone Market Revenues & Volume By Drug Developers for the Period 2022 - 2032F
- China Steroid Hormone Import Export Trade Statistics
- Market Opportunity Assessment By Hormone Type
- Market Opportunity Assessment By Source
- Market Opportunity Assessment By Application Area
- Market Opportunity Assessment By End User
- China Steroid Hormone Top Companies Market Share
- China Steroid Hormone Competitive Benchmarking By Technical and Operational Parameters
- China Steroid Hormone Company Profiles
- China Steroid Hormone Key Strategic Recommendations
Market Covered
Segments analysed in this report are listed below.
By Hormone Type
- Corticosteroids
- Anabolic Steroids
- Estrogens & Androgens
- Progestogens
By Source
- Synthetic
- Plant-Based
- Animal-Based
- Biosynthetic
By Application Area
- Anti-inflammatory Drugs
- Muscle Growth Therapy
- Hormonal Treatments
- Birth Control
By End User
- Pharmaceutical Companies
- Research Institutions
- Healthcare Manufacturers
- Drug Developers







